Los Angeles Capital Management
MEDP icon

Los Angeles Capital Management’s Medpace MEDP Stock Holding History

Los Angeles Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.9M Sell
45,686
-44,055
-49% -$22.6M 0.09% 181
2025
Q4 		$52.1M Buy
89,741
+9,380
+12% +$5.32M 0.18% 99
2025
Q3 		$41.3M Buy
80,361
+75,696
+1,623% +$33M 0.14% 118
2025
Q2 		$1.46M Sell
4,665
-22,843
-83% -$6.86M 0.01% 534
2025
Q1 		$8.38M Sell
27,508
-65,852
-71% -$22.2M 0.04% 232
2024
Q4 		$31M Sell
93,360
-70,967
-43% -$24.1M 0.13% 144
2024
Q3 		$54.9M Sell
164,327
-40,707
-20% -$15.5M 0.22% 96
2024
Q2 		$84.4M Sell
205,034
-55,411
-21% -$21.9M 0.3% 69
2024
Q1 		$105M Buy
260,445
+6,320
+2% +$2.22M 0.36% 61
2023
Q4 		$77.9M Buy
254,125
+82,068
+48% +$22.2M 0.29% 78
2023
Q3 		$41.7M Sell
172,057
-16,767
-9% -$4.29M 0.18% 112
2023
Q2 		$45.3M Buy
188,824
+165,032
+694% +$34.3M 0.18% 116
2023
Q1 		$4.47M Sell
23,792
-247
-1% -$51.1K 0.02% 364
2022
Q4 		$5.11M Buy
24,039
+6,125
+34% +$1.22M 0.02% 375
2022
Q3 		$2.82M Sell
17,914
-800
-4% -$128K 0.01% 446
2022
Q2 		$2.8M Buy
18,714
+6,203
+50% +$898K 0.01% 456
2022
Q1 		$2.05M Buy
12,511
+89
+0.7% +$14.7K 0.01% 527
2021
Q4 		$2.7M Buy
+12,422
New +$2.6M 0.01% 450
2021
Q2 		– Sell
-3,468
Closed -$569K – 1620
2021
Q1 		$569K Sell
3,468
-9,678
-74% -$1.48M ﹤0.01% 1164
2020
Q4 		$1.83M Sell
13,146
-12,814
-49% -$1.62M 0.01% 687
2020
Q3 		$2.9M Sell
25,960
-17,600
-40% -$2.04M 0.01% 473
2020
Q2 		$4.05M Sell
43,560
-3,025
-6% -$257K 0.02% 439
2020
Q1 		$3.42M Sell
46,585
-31,340
-40% -$2.72M 0.02% 410
2019
Q4 		$6.55M Sell
77,925
-4,650
-6% -$360K 0.03% 357
2019
Q3 		$6.94M Buy
82,575
+28,770
+53% +$2.17M 0.04% 347
2019
Q2 		$3.52M Buy
53,805
+43,696
+432% +$2.52M 0.02% 520
2019
Q1 		$596K Sell
10,109
-44,816
-82% -$2.68M ﹤0.01% 1031
2018
Q4 		$2.91M Buy
54,925
+835
+2% +$45.8K 0.02% 469
2018
Q3 		$3.24M Buy
+54,090
New +$2.96M 0.02% 544

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Los Angeles Capital Management's MEDP Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Medpace (MEDP) stake by 49% in Q1 2026, selling an estimated $22.6M and leaving 45,686 shares worth $21.9M. The position accounts for 0.09% of the portfolio, ranked #181.

Los Angeles Capital Management first reported a position in MEDP in Q3 2018 and has held it in 29 quarters since. The position peaked at $105M in Q1 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Los Angeles Capital Management held 45,686 shares of Medpace worth $21.9M as of Q1 2026.
  • Los Angeles Capital Management sold 44,055 Medpace shares in Q1 2026, an estimated $22.6M.
  • Medpace made up 0.09% of Los Angeles Capital Management's portfolio in Q1 2026, its #181 holding.
  • Los Angeles Capital Management first reported a position in Medpace in Q3 2018 and has held it in 29 quarters since.
  • Los Angeles Capital Management's Medpace position peaked at $105M in Q1 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.